早产儿代谢性骨病研究进展

doi:10.11852/zgetbjzz2018-26-09-14

中国儿童保健杂志 ›› 2018, Vol. 26 ›› Issue (9): 981-984.DOI: 10.11852/zgetbjzz2018-26-09-14

早产儿代谢性骨病研究进展

宋迎冬^*,王利平^*,徐丁,李艳萍,姜春倩,孙妮

兰州大学第二医院,甘肃兰州 730030

收稿日期:2018-05-15 发布日期:2018-09-10 出版日期:2018-09-10
通讯作者: 徐丁,E-mail:xud@lzu.edu.cn。
作者简介:宋迎冬(1991-),女,在读硕士研究生,主要研究方向为新生儿疾病。王利平(1992-),女,在读硕士研究生,主要研究方向为儿科疾病。^*为共同第一作者。
基金资助:
兰州大学第二医院院内课题(sdkyjj-28)

Research progress on metabolic bone disease of prematurity

SONG Ying-dong^*,WANG Li-ping^*, XU Ding, LI Yan-ping, JIANG Chun-qian, SUN Ni

The Second Hospital of Lanzhou University,Lanzhou,Gansu 730030,China

Received:2018-05-15 Online:2018-09-10 Published:2018-09-10
Contact: XU Ding, E-mail: xud@lzu.edu.cn

摘要/Abstract

摘要： 早产儿代谢性骨病,是指由于体内钙磷代谢紊乱所致的骨矿物质含量的异常,导致骨小梁数量减少、骨皮质变薄等骨骼改变。该病早期缺乏典型的临床症状或者敏感且特异的检查指标,后期确诊已出现严重并发症,如出现佝偻病或病理性骨折。所以早期发现、明确诊断和有效治疗亟待解决。本文主要就有关早产儿代谢性骨病的临床表现、诊断、治疗及预防措施进行综述。

关键词: 早产儿, 代谢性骨病, 诊断, 治疗, 预防

Abstract: Metabolic bone disease (MBD) of prematurity is defined as disorder of diminished bone mineralization,leading to bone changes, decrease of bone trabecular and cortex of bone. There are no typical clinical symptoms or sensitive and specific examination indicators in the early stage of the disease. While serious complications have occurred in later diagnosis, such as rickets or pathological fracture. So it is important to discover,diagnose and treat early. This paper focuses on the publications in recent years to summarize the background,influencing factors,clinical manifestation,diagnosis,treatment and prevention measures of MBD.

Key words: premature, metabolic bone disease, diagnosis, treatment, prevention

中图分类号:

R179

宋迎冬,王利平,徐丁,李艳萍,姜春倩,孙妮. 早产儿代谢性骨病研究进展[J]. 中国儿童保健杂志, 2018, 26(9): 981-984.

SONG Ying-dong,WANG Li-ping, XU Ding, LI Yan-ping, JIANG Chun-qian, SUN Ni. Research progress on metabolic bone disease of prematurity[J]. journal1, 2018, 26(9): 981-984.

参考文献

[1] Nallagonda S, Nallagonda M, Deorukhkar A. Metabolic bone disease of prematurity - an overview[J]. Paed Child Healt-can 2017, 27(1):14-17.
[2] Jonathan P,Alastair R,Charles G,et al.Metabolic bone disease[J].J Orthop Trauma,2017,31(5):306-311.
[3] Chhina AS, Shenoi A, Nagendra N, et al. Vitamin D and metabolic bone parameters in preterm neonates[J]. Indian Pediatr, 2016,53(11):1023.
[4] Figuerasaloy J, ÁlvarezDomínguez E, Pérezfernández JM, et al. Metabolic bone disease and bone mineral density in very preterm infants[J]. J Pediatr,2014,164(3):499-504.
[5] Harrison CM, Johnson K, Mckechnie E. Osteopenia of prematurity: a national survey and review of practice[J]. Acta Paediatr, 2008, 97(4):407-413.
[6] Rustico SE, Calabria AC, Garber SJ. Metabolic bone disease of prematurity[J].J Clin Endocr Metab,2014,1(3):85-91.
[7] Gaio P, Verlato G,Daverro M, et al.Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia[J].Clin Nutr ESPEN,2017,23:234-239.
[8] 张荣娜,修文龙.早产儿代谢性骨病[J].实用儿科临床杂志,2011,26(8):624-627.
[9] 欧丽黎,李吉华.骨碱性磷酸酶、血25-羟维生素D₃联合骨密度对小儿维生素D缺乏性佝偻病的诊断价值[J].医学综述,2018,24(7):1449-1452.
[10] 赵春生,裴春红.成年男性碱性磷酸酶活力降低的主要临床意义[J].中国医学创新,2011,8(12):104-105.
[11] 庄兴,陈福祥.成纤维母细胞生长因子23的研究进展[J].国际检验医学杂志,2011,32(7):778-781.
[12] 朱万胜,吴道全.fgf-23与慢性肾脏病的研究进展[J].西部医学,2017,29(4):588-592.
[13] 袭艳梅,侯洪涛.成纤维细胞生长因子23在早产儿代谢性骨病的意义[J].实用医学杂志,2018,34(2):235-238.
[14] Munns CF, Shaw N, Kiely M, et al. Global consensus recommendations on prevention and management of nutritional Rickets[J]. Horm Res Paediat, 2016, 85(2):83-106.
[15] Moreira A, Swischuk L, Malloy M, et al. Parathyroid hormone as a marker for metabolic bone disease of prematurity[J]. J Perinatol, 2014, 34(10):787-791.
[16] Rustico SE, Kelly A, Monk HM, et al. Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: a preliminary study[J]. J Clin Endocr Metab, 2015, 2(1):14-20.
[17] 李源斌,陆妹.早产儿血清25羟基维生素D₃水平与超声骨密度的相关性研究[J].中国当代医药,2017,4(13):106-108.
[18] 郭晓红.骨钙素检测的发展及其临床应用[J].中国卫生检验杂志,2017,27(18):2731-2733.
[19] 阙文君,冯正平.骨转换生化标志物的研究进展[J].中国骨质疏松杂志,2014,20(5):575-579.
[20] Bartell SM,Rayalam S, Ambati S, et al. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression ofosteogenic genes in leptin deficientob/ob mice[J]. J Bone Miner Res, 2011,26(8):1710-1720.
[21] Berry PA, Jones SW, Cicuttini FM, et al. Temporal relationship between serumAdipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with cinical kee oteoarthritis[J].Arthritis Rheum-us, 2011, 63(3):700-707.
[22] 王峰,郑陆.脂联素、瘦素与运动及骨代谢的关系[J].中国骨质疏松杂志,2016,22(2):221-227.
[23] Reid P, Holen I. Pathophysiological roles of osteoprotegerin (OPG)[J]. Eur J Cell Biol, 2009, 88(1):1.
[24] Kostenuik PJ, Nguyen HQ, Mccabe J, et al. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in Knock-in mice that express chimeric (murine/human) RANKL[J]. J Bone Miner Res, 2009,24(2):182-195.
[25] Visser F, Sprij AJ, Brus F. The validity of biochemical markers in metabolic bone disease in preterm infants: a systematic review[J]. Acta Paediatr, 2012,101(6):562-568.
[26] 张乐嘉,丁国芳.早产儿代谢性骨病[J].中国实用儿科杂志,2015,30(2):100-104.
[27] Rack B, Lochmüller EM, Janni W, et al. Ultrasound for the assessment of bone quality in preterm and term infants[J]. J Perinatol, 2012, 32(3):218-226.
[28] 孔令凯,孔祥永.早产儿代谢性骨病[J].中国医刊,2014,49(3):21-23.
[29] Mcdevitt H, Tomlinson C, White MP, et al. Changes in quantitative ultrasound in infants born at less than 32 weeks' gestation over the first 2 years of life: influence of clinical and biochemical changes[J]. Calcified Tissue Int, 2007, 81(4):263-269.
[30] 王丹虹,陈平洋.早产儿代谢性骨病防治进展[J].国际儿科学杂志,2014,41(5):508-510.
[31] Bozzetti V,Tagliabue P.Metabolic Bone disease in pretermn newborn:an update on nutritional issues[J]. Ital J Pediatr,2009,35(1):20.
[32] Abrams SA. In utero physiology: role in nutrient delivery and fetal development for calcium, phosphorus, and vitamin D[J]. Am J Clin Nutr, 2007, 85(2):604S.
[33] 韩露艳,王丹华.早产儿代谢性骨病[J].中国新生儿科杂志,2010,25(4):253-254.
[34] Agostoni C, Buonocore G, Carnielli VP, et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition[J]. J Pediatr Gastr Nutr, 2010,50(1):85-91.
[35] Hovi P,Andersson S,Jarvenpaa AL,et al. Decreased bone mineral density in adults born with very low birth weight:a cohortstudy[J].PloS Med,2009,6(8):e1000135.
[36] Schulzke SM, Kaempfen S, Trachsel D,et al.Physical activity programs for promoting bone mineralization and growth in preterm infants[J].Cochrane Database Syst Rev,2014,4:CD005387.

早产儿代谢性骨病研究进展

Research progress on metabolic bone disease of prematurity

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	向伟. 儿童青少年脂质异常血症早期预防与成人期心血管健康[J]. 中国儿童保健杂志, 2023, 31(7): 697-702.
[2]	李荣, 李年, 吴丹丹, 黄荣, 陈银花. 盐酸哌甲酯缓释片对注意缺陷多动障碍儿童生长的影响[J]. 中国儿童保健杂志, 2023, 31(7): 731-735.
[3]	张丹, 张军, 杨钰荣, 曹咪, 闫敬敏, 朱璐阳. 肠道菌群与早产儿脑发育及神经认知行为关系的研究[J]. 中国儿童保健杂志, 2023, 31(7): 756-759.
[4]	冯骁, 陈凌, 赵红缨, 黄蕊, 林辰曦, 庄丽娟. 不同脐带挤压方式对极早产儿结局的影响[J]. 中国儿童保健杂志, 2023, 31(7): 794-798.
[5]	郑亭玉, 张春宇, 杨飞, 郑芳, 张梦霞, 夏露萍, 徐孙超. 营养支持小组管理模式对早产儿生长发育及免疫功能的影响[J]. 中国儿童保健杂志, 2023, 31(5): 555-558.
[6]	夏正龙, 宋燕燕. 支气管肺发育不良早产儿神经发育研究[J]. 中国儿童保健杂志, 2023, 31(4): 390-394.
[7]	李静兰, 孙文强, 朱雪萍. 早产儿支气管肺发育不良相关预测模型研究[J]. 中国儿童保健杂志, 2023, 31(4): 395-398.
[8]	王娜, 李晓莺. 早产儿神经发育评估的进展[J]. 中国儿童保健杂志, 2023, 31(4): 404-407.
[9]	任力, 黑明燕, 齐宇洁, 靳绯, 翁景文, 董世霄, 沈艳华, 姜敏. 早产儿喂养对坏死性小肠结肠炎发病的影响[J]. 中国儿童保健杂志, 2023, 31(4): 438-441.
[10]	王少雯, 张贻霞, 陈静静, 魏秀丽, 叶蓓, 方拴锋. Gesell发展诊断量表在语言相关的发育性疾病中的应用[J]. 中国儿童保健杂志, 2023, 31(4): 442-445.
[11]	陈峰, 张宇. 多胞胎和单胞胎早产儿神经发育的回顾性研究[J]. 中国儿童保健杂志, 2023, 31(4): 451-456.
[12]	王晶, 项思嘉, 鲁莹, 杨蕾, 胡小沙, 钱君, 池霞, 张敏. 早产儿3周岁体格生长及体成分分析[J]. 中国儿童保健杂志, 2023, 31(4): 457-460.
[13]	郑水英, 罗艳赟. 早产儿喂养不耐受的临床表现及相关影响因素[J]. 中国儿童保健杂志, 2023, 31(4): 461-464.
[14]	柯晓燕. 孤独症谱系障碍早期识别与早期诊断的现状与挑战[J]. 中国儿童保健杂志, 2023, 31(3): 238-240.
[15]	赵丽华, 李晶. 孤独症谱系障碍儿童非典型人际同步表现及其神经机制[J]. 中国儿童保健杂志, 2023, 31(3): 274-278.